Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - Bloomberg
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva says its generic Adderall shortage will last another 2 to 3 months (NYSE:TEVA) | Seeking Alpha
Teva, Units Held Liable for Fueling N.Y. Opioid Crisis - Bloomberg
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva Considering Cutting up to 10,000 Jobs: Bloomberg
Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says | Barron's
Teva Pharmaceuticals - Wikipedia
Teva: Reportedly Planning Thousands of Layoffs in the U.S. | Fortune
252 Teva Pharmaceuticals Photos and Premium High Res Pictures - Getty Images
CVS, Teva, Allergan and Endo reach $878 million deal with Florida over the opioid crisis - STAT
Teva's Trouble Was Predicted. Path to Recovery Not as Clear - Bloomberg
Teva Pharmaceuticals Names Kare Schultz As New CEO | Fortune
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Justice Dept reportedly may file charges in its generic-drug probe by year-end
Ex-Teva Chairman, Blockchain Investor Accused of Pump-and-Dump Scheme - WSJ
Teva Offers Drugs Valued at $23 Billion to End Opioid Suits - Bloomberg
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - Bloomberg
Teva to lay off 25% of workforce, suspends dividend - BNN Bloomberg
